Medicament for children - the entry into force of the Pediatric regularization

(openPR) - for January 2007 the entry into force of the Pediatric becomes regularization, which regulation for child medicaments in Europe expects. Thus some changes for the coworkers are connected in the pharmaceutical enterprise: The execution of clinical studies at children will become for most medicaments obligation. In addition a PIP, thus a Paediatric Investigation plan, must be provided and approved.

FORUM Institut for management, one of the prominent training further offerers of Germany, offers the participation in a conference to interested coworkers of pharmaceutical enterprises for this topic. The two-day conference takes place to 02.05. and 03.05.2007 in Frankfurt. Further information to the conference and to the organizer finds you under:
www.forum-institut.de/veranstaltung.aspSemNr=0705291

Let comprehensively about the regulatorischen defaults and possibilities and the practical conversion of the defaults into clinical examinations of children inform. Experience additionally, which advantages can provide you by the medicament examination of children regarding patent and document protection.

Contact:
Dr. Henriette wolf-small
Range chief Pharma
FORUM Institut for management GmbH, Heidelberg
Vangerowstrasse 18
69115 Heidelberg
Tel. 06221 500,680
Fax. 06221 500,618
h.wolf-klein@forum-institut.de

The FORUM Institut for management GmbH stands for 25 years for practice-oriented and founded knowledge transfer in enterprise questions on highest level. FORUM is 100% daughter of Springer Science + Business Media, one the offerer for science and technical literature, leading world-wide. The broadly varied offer covers conferences and conferences to current developments, in addition, seminars and training courses of several days. In the year 2005 more than 30,000 high-level personnel from almost all countries of Europe and from the United States participated on over 1.400 meetings of the institutes for forum.

Dieser Artikel wurde veröffentlicht auf
OpenPR - http://openpr.de/news/120970/Arzneimittel-fuer-Kinder-Inkrafttreten-der-Pediatric-Regulation.html